top of page

Diseases

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Neoadjuvant nivolumab plus chemotherapy: Examining the clinical trial that led to FDA approval

4 min read

Neoadjuvant nivolumab plus chemotherapy: Examining the clinical trial that led to FDA approval

Immunotherapy is transforming cancer treatment. One such immunotherapy drug called, nivolumab has been approved by FDA for lung cancer.

18 views

Collaborators

IIT Guwahati

University of Manchester

Rhenix Lifesciences

American university of Sharjah

IIT Delhi

subscribe green.png

Get new content delivered directly to your inbox.

bottom of page